Should aspirin be used for prophylaxis of COVID-19-induced coagulopathy?

Mohamed-Hussein, Aliae A R; Aly, Karim M E; Ibrahim, Mohamed-Eltaher A A

Mohamed-Hussein, Aliae A R; Aly, Karim M E; Ibrahim, Mohamed-Eltaher A A.

Mohamed-Hussein AAR; Department of Pulmonology, Assiut University Hospitals, Assiut, Egypt.
Aly KME; Cardiology Department, Assiut University Hospitals, Assiut, Egypt.
Ibrahim MAA; Tropical, Gastroenterology and Hepatology Department, Alrajhi Hospital, Assiut University Hospitals, Assiut, Egypt.

Med Hypotheses ; 144: 109975, 2020 11.

Article in English | MEDLINE | ID: covidwho-594981

Subject(s)

Aspirin/therapeutic use; Blood Coagulation Disorders/prevention & control; COVID-19 Drug Treatment; COVID-19/complications; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Anticoagulants/therapeutic use; Autopsy; Blood Coagulation Disorders/virology; Hemorrhage/prevention & control; Hemorrhage/virology; Humans; Models, Theoretical; Stroke/complications; Stroke/prevention & control

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Blood Coagulation Disorders / Aspirin / COVID-19 / COVID-19 Drug Treatment Topics: Long Covid Limits: Humans Language: English Journal: Med Hypotheses Year: 2020 Document Type: Article Affiliation country: J.mehy.2020.109975

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google